Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiping Chen

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Vaccine|August 5, 2020
Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in ChinaShaohong Yan, Haiping Chen, Zhenguo Zhang, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in ChinaXuewen Tang, Yanhui Xiao, Xuan Deng, et al.
Scientific Reports|March 16, 2016
Suppression of Structural Phase Transition in VO2 by Epitaxial Strain in Vicinity of Metal-insulator TransitionMengmeng Yang, Yuanjun Yang, Bin Hong, et al.
Vaccines|July 27, 2022
Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes MellitusYuntao Zhang, Haiping Chen, Jun Lv, et al.
Clinical Complementary Medicine and Pharmacology|April 15, 2024
Treatment Effects of Integrated TCM and Western Medicine Treatment Scheme on COVID-19: A Single-armed Clinical TrialJianfeng Bao, Zhijun Xie, Shourong Liu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 13, 2023
Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in ChinaYan Xu, Haiping Chen, Binbing Wang, et al.
Vaccines|June 24, 2022
Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in ChinaXiaodong Liu, Shaoying Chang, Ruize Wang, et al.
Vaccine|August 5, 2022
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trialHaiping Chen, Zhuoying Huang, Shaoying Chang, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Vaccine|August 5, 2020
Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in ChinaShaohong Yan, Haiping Chen, Zhenguo Zhang, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in ChinaXuewen Tang, Yanhui Xiao, Xuan Deng, et al.
Scientific Reports|March 16, 2016
Suppression of Structural Phase Transition in VO2 by Epitaxial Strain in Vicinity of Metal-insulator TransitionMengmeng Yang, Yuanjun Yang, Bin Hong, et al.
Vaccines|July 27, 2022
Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes MellitusYuntao Zhang, Haiping Chen, Jun Lv, et al.
Clinical Complementary Medicine and Pharmacology|April 15, 2024
Treatment Effects of Integrated TCM and Western Medicine Treatment Scheme on COVID-19: A Single-armed Clinical TrialJianfeng Bao, Zhijun Xie, Shourong Liu, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 13, 2023
Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in ChinaYan Xu, Haiping Chen, Binbing Wang, et al.
Vaccines|June 24, 2022
Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in ChinaXiaodong Liu, Shaoying Chang, Ruize Wang, et al.
Vaccine|August 5, 2022
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trialHaiping Chen, Zhuoying Huang, Shaoying Chang, et al.
Pageof 10